FHB
RPRX icon

First Hawaiian Bank’s Royalty Pharma RPRX Stock Holding History

First Hawaiian Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,119
Closed -$267K – 904
2024
Q2 		$267K Hold
10,119
– – 0.01% 716
2024
Q1 		$307K Buy
+10,119
New +$298K 0.01% 677

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Hawaiian Bank's RPRX Position: Q3 2024 in Review

First Hawaiian Bank sold out of Royalty Pharma (RPRX) in Q3 2024, closing a stake of 10,119 shares — an estimated $267K sold.

First Hawaiian Bank first reported a position in RPRX in Q1 2024 and held it in 2 quarters. The position peaked at $307K in Q1 2024. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

  • First Hawaiian Bank reported no remaining Royalty Pharma position as of Q3 2024 after selling out during the quarter.
  • First Hawaiian Bank sold 10,119 Royalty Pharma shares in Q3 2024, an estimated $267K.
  • First Hawaiian Bank first reported a position in Royalty Pharma in Q1 2024 and held it in 2 quarters.
  • First Hawaiian Bank's Royalty Pharma position peaked at $307K in Q1 2024.
  • 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on First Hawaiian Bank's 13F filing for Q3 2024, filed 4 Oct 2024.